First, do no harm? Study finds association between androgen deprivation therapy and increased risk of Alzheimer’s disease

By SharpBrains | December 15, 2015

Pros­trate Can­cer Treat­ment Tied To Alzheimer’s Risk (New York Times): “Hor­mone ther­a­py, a com­mon treat­ment for prostate can­cer, is asso­ci­at­ed with an increased risk for Alzheimer’s dis­ease, a new study has found…Overall, those treat­ed with hor­mone ther­a­py had an 88 per­cent increased risk of Alzheimer’s com­pared with oth­er patients. The longer 

Read More